Neuroinflammation and comorbidity of pain and depression

Pharmacological Reviews

Volumn 66, Issue 1, 2014, Pages 80-101

  Walker, Adam K ^a   Kavelaars, A ^a   Heijnen, C J ^a   Dantzer, R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CYTOKINE; G PROTEIN COUPLED RECEPTOR KINASE 2; GLUTAMIC ACID; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE;

ARTICLE; BRAIN DEPTH STIMULATION; CHRONIC INFLAMMATION; CHRONIC PAIN; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DOWN REGULATION; ENCEPHALITIS; ENZYME INHIBITION; GABAERGIC TRANSMISSION; HUMAN; ILLNESS BEHAVIOR; METABOLITE; MOLECULAR BIOLOGY; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; PAIN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; COMORBIDITY; DEPRESSION; HUMANS; INFLAMMATION; PAIN;

EID: 84890964966     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.113.008144     Document Type: Article

References (185)

1. Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, and Schwartzman RJ (2005) Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 116:213-219.
2. Anthony DC, Bolton SJ, Fearn S, and Perry VH (1997) Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in bloodbrain barrier permeability in rats. Brain 120:435-444.
3. Apkarian AV, Lavarello S, Randolf A, Berra HH, Chialvo DR, Besedovsky HO, and del Rey A (2006) Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain. Neurosci Lett 407:176-181.
4. Aragay AM, Ruiz-Gómez A, Penela P, Sarnago S, Elorza A, Jiménez-Sainz MC, and Mayor F Jr (1998) G protein-coupled receptor kinase 2 (GRK2): mechanisms of regulation and physiological functions. FEBS Lett 430:37-40.
5. Arnow BA, Hunkeler EM, Blasey CM, Lee J, Constantino MJ, Fireman B, Kraemer HC, Dea R, Robinson R, and Hayward C (2006) Comorbid depression, chronic pain, and disability in primary care. Psychosom Med 68:262-268.
6. Austin TM and Delpire E (2011) Inhibition of KCC2 in mouse spinal cord neurons leads to hypersensitivity to thermal stimulation. Anesth Analg 113:1509-1515.
7. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, and Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91-95.
8. Backonja MM, Coe CL, Muller DA, and Schell K (2008) Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol 195: 157-163.
9. Bair MJ, Wu J, Damush TM, Sutherland JM, and Kroenke K (2008) Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 70:890-897.
10. Ballok DA and Sakic B (2008) Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain? Brain Behav Immun 22:1208-1216.
11. Banks WA (2005) Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des 11:973-984.
12. Banks WA and Kastin AJ (1991) Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci 48:PL117-PL121.
13. Banks WA, Kastin AJ, and Durham DA (1989) Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull 23:433-437.
14. Banks WA, Kastin AJ, and Gutierrez EG (1993) Interleukin-1 alpha in blood has direct access to cortical brain cells. Neurosci Lett 163:41-44.
15. Banks WA, Ortiz L, Plotkin SA, and Kastin AJ (1991) Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 259:988-996.
16. Basterzi AD, Aydemir C, Kisa C, Aksaray C, Tuzer V, Yazici K, and Goka E (2005) IL-6 levels decrease with SSRI treatment in patients with major depression. Human Psychopharmacol 20:473-476.
17. Bell RF, Eccleston C, and Kalso EA (2012) Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 11:CD003351.
18. Bennett GJ and Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
19. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, and Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351-354.
20. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1-5.
21. Binns BC, Huang Y, Goettl VM, Hackshaw KV, and Stephens RL Jr (2005) Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model. Brain Res 1041:38-47.
22. Blatteis CM, Sehic E, and Li S (2000) Pyrogen sensing and signaling: old views and new concepts. Clin Infect Dis 31 (Suppl 5):S168-S177.
23. Bluthé RM, Michaud B, Poli V, and Dantzer R (2000) Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav 70:367-373.
24. Bluthé RM, Walter V, Parnet P, Layé S, Lestage J, Verrier D, Poole S, Stenning BE, Kelley KW, and Dantzer (1994) Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III 317:499-503.
25. Boyce-Rustay JM, Honore P, and Jarvis MF (2010b) Animal models of acute and chronic inflammatory and nociceptive pain. Methods Mol Biol 617:41-55.
26. Boyce-Rustay JM, Zhong C, Kohnken R, Baker SJ, Simler GH, Wensink EJ, Decker MW, and Honore P (2010a) Comparison of mechanical allodynia and the affective component of inflammatory pain in rats. Neuropharmacology 58:537-543.
27. Brady LS, Lynn AB, Herkenham M, and Gottesfeld Z (1994) Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J Neurosci 14: 4951-4964.
28. Cady RJ, Glenn JR, Smith KM, and Durham PL (2011) Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization. Mol Pain 7:94.
29. Cairns BE, Sessle BJ, and Hu JW (1998) Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles. J Neurosci 18:8056-8064.
30. Calvo M, Zhu N, Grist J, Ma Z, Loeb JA, and Bennett DLH (2011) Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. Glia 59:554-568.
31. Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist J, Loeb JA, and Bennett DL (2010) Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci 30: 5437-5450.
32. Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, and Miller AH (2003) Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry 54:906-914.
33. Capuron L, Ravaud A, and Dantzer R (2000) Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 18: 2143-2151.
34. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, and Dantzer R (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7:468-473.
35. Coelho AM, Fioramonti J, and Bueno L (2000) Brain interleukin-1b and tumor necrosis factor-a are involved in lipopolysaccharide-induced delayed rectal allodynia in awake rats. Brain Res Bull 52:223-228.
36. Ching S, He L, Lai W, and Quan N (2005) IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 19:127-137.
37. Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C, Hörtnagl H, Riva MA, Sprengel R, and Gass P (2008) AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J 22:3129-3134.
38. Connor TJ, Song C, Leonard BE, Merali Z, and Anisman H (1998) An assessment of the effects of central interleukin-1b,-2,-6, and tumor necrosis factor-a administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neurosci 84:923-933.
39. Cowen PJ, Parry-Billings M, and Newsholme EA (1989) Decreased plasma tryptophan levels in major depression. J Affect Disord 16:27-31.
40. Cui JG, Holmin S, Mathiesen T, Meyerson BA, and Linderoth B (2000) Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 88:239-248.
41. Dantzer R (2004) Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500:399-411.
42. Dantzer R and Kelley KW (1989) Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 44:1995-2008.
43. Decosterd I and Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149-158.
44. Dharmshaktu P, Tayal V, and Kalra BS (2012) Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol 52:6-17.
45. Eijkelkamp N, Heijnen CJ, Willemen HL, Deumens R, Joosten EA, Kleibeuker W, den Hartog IJ, van Velthoven CT, Nijboer C, and Nassar MA, et al. (2010a) GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain. J Neurosci 30:2138-2149.
46. Eijkelkamp N, Wang H, Garza-Carbajal A, Willemen HL, Zwartkruis FJ, Wood JN, Dantzer R, Kelley KW, Heijnen CJ, and Kavelaars A (2010b) Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK. J Neurosci 30:12806-12815.
47. Fava M and Davidson KG (1996) Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 19:179-200.
48. Finnerup NB, Otto M, McQuay HJ, Jensen TS, and Sindrup SH (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118:289-305.
49. Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J, Kelley KW, Dantzer R, and Castanon N (2007) Lipopolysaccharide induces delayed Fos B/Delta Fos B immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinol 32:516-531.
50. Fu KY, Light AR, and Maixner W (2000) Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin. Neuroscience 101:1127-1135.
51. Fu X, Zunich SM, O'Connor JC, Kavelaars A, Dantzer R, and Kelley KW (2010) Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3-dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation 7:43.
52. Fuccio C, Luongo C, Capodanno P, Giordano C, Scafuro MA, Siniscalco D, Lettieri B, Rossi F, Maione S, and Berrino L (2009) A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. Eur J Pharmacol 603:42-49.
53. Funakoshi H, Kanai M, and Nakamura T (2011) Modulation of Tryptophan Metabolism, Promotion of Neurogenesis and Alteration of Anxiety-Related Behavior in Tryptophan 2,3-Dioxygenase-Deficient Mice. Int J Tryptophan Res 4:7-18.
54. Garcia LS, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries GR, Gavioli EC, and Kapczinski F, et al. (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32:140-144.
55. Garcia LS, Comim CM, Valvassori SS, Réus GZ, Stertz L, Kapczinski F, Gavioli EC, and Quevedo J (2009) Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 33:450-455.
56. García-Sevilla JA, Alvaro-Bartolomé M, Díez-Alarcia R, Ramos-Miguel A, Puigdemont D, Pérez V, Alvarez E, and Meana JJ (2010) Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients. Eur Neuropsychopharmacol 20:721-730.
57. Goehler LE, Gaykema RP, Nguyen KT, Lee JE, Tilders FJ, Maier SF, and Watkins LR (1999) Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J Neurosci 19:2799-2806.
58. Goldstein DJ, Lu Y, Detke MJ, Lee TC, and Iyengar S (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109-118.
59. Granados-Soto V, Arguelles CF, and Alvarez-Leefmans FJ (2005) Peripheral and central antinociceptive action of Na+-K+-2Cl-cotransporter blockers on formalininduced nociception in rats. Pain 114:231-238.
60. Grange-Midroit M, García-Sevilla JA, Ferrer-Alcón M, La Harpe R, Huguelet P, and Guimón J (2003) Regulation of GRK 2 and 6, beta-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression. Brain Res Mol Brain Res 111:31-41.
61. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, and Corey-Lisle PK (2003) The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 64:1465-1475.
62. Guillemin GJ, Smythe G, Takikawa O, and Brew BJ (2005) Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49:15-23.
63. Guo LH and Schluesener HJ (2007) The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors. Cell Mol Life Sci 64: 1128-1136.
64. Gureje O, Von Korff M, Simon GE, and Gater R (1998) Persistent pain and wellbeing: A World Health Organization study in primary care. JAMA 280:147-151.
65. Gutierrez EG, Banks WA, and Kastin AJ (1993) Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 47:169-176.
66. Hannestad J, DellaGioia N, and Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36:2452-2459.
67. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, and Critchley HD (2009) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66:407-414.
68. Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF, and Godbout JP (2008) Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 5:15.
69. Hess A, Axmann R, Rech J, Finzel S, Heindl C, Kreitz S, Sergeeva M, Saake M, Garcia M, and Kollias G, et al. (2011) Blockade of TNF-a rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci USA 108:3731-3736.
70. Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, and Markey SP (1996) Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 320: 595-597.
71. Huang X, McMahon J, Yang J, Shin D, and Huang Y (2012) Rapamycin downregulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats. Neuroscience 219:33-47.
72. Institute of Medicine of the National Academies (2011) Relieving pain in America: A blueprint for transforming prevention, care, education, and research, The National Academies Press, Washington, DC.
73. Isik A, Koca SS, Ozturk A, and Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26:872-878.
74. Jackson DL, Graff CB, Richardson JD, and Hargreaves KM (1995) Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur J Pharmacol 284:321-325.
75. Johansen JP, Fields HL, and Manning BH (2001) The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci USA 98:8077-8082.
76. Kahle KT, Staley KJ, Nahed BV, Gamba G, Hebert SC, Lifton RP, and Mount DB (2008) Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol 4:490-503.
77. Kalkman HO (2011) Alterations in the expression of neuronal chloride transporters may contribute to schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35: 410-414.
78. Kent S, Bluthé RM, Dantzer R, Hardwick AJ, Kelley KW, Rothwell NJ, and Vannice JL (1992b) Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci USA 89:9117-9120.
79. Kent S, Bluthé RM, Kelley KW., and Dantzer R (1992a) Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13:24-28.
80. Kent S, Kelley KW, and Dantzer R (1992c) Effects of lipopolysaccharide on foodmotivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist. Neurosci Lett 145:83-86.
81. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, and Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602.
82. Kim H, Chen L, Lim G, Sung B, Wang S, McCabe MF, Rusanescu G, Yang L, Tian Y, and Mao J (2012) Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 122:2940-2954.
83. Kim SH and Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363.
84. Kim JS, Schmid-Burgk W, Claus D, and Kornhuber HH (1982) Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr 232:299-304.
85. Kleibeuker W, Gabay E, Kavelaars A, Zijlstra J, Wolf G, Ziv N, Yirmiya R, Shavit Y, Tal M, and Heijnen CJ (2008) IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2. Brain Behav Immun 22:200-208.
86. Knabl J, Witschi R, Hösl K, Reinold H, Zeilhofer UB, Ahmadi S, Brockhaus J, Sergejeva M, Hess A, and Brune K, et al. (2008) Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 451:330-334.
87. Knerlich-Lukoschus F, Noack M, von der Ropp-Brenner B, Lucius R, Mehdorn HM, and Held-Feindt J (2011) Spinal cord injuries induce changes in CB1 cannabinoid receptor and C-C chemokine expression in brain areas underlying circuitry of chronic pain conditions. J Neurotrauma 28:619-634.
88. Konsman JP, Tridon V, and Dantzer R (2000) Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience 101:957-967.
89. Kraus J, Engelhardt B, Chatzimanolis N, Bauer R, Tofighi J, Kuehne BS, Laske C, Stolz E, Frielinghaus P, and Schaefer C, et al. (2002) Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRImeasures of subclinical disease severity and activity. J Neuroimmunol 122:175-185.
90. Krell HV, Leuchter AF, Cook IA, and Abrams M (2005) Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics 46:379-384.
91. Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, and Tu W (2009) Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 301:2099-2110.
92. Krystal AD, Sutherland J, and Hochman DW (2012) Loop diuretics have anxiolytic effects in rat models of conditioned anxiety. PLoS ONE 7:e35417.
93. Kwidzinski E and Bechmann I (2007) IDO expression in the brain: a double-edged sword. J Mol Med (Berl) 85:1351-1359.
94. Li YQ, Li H, Wei J, Qu L, and Wu LA (2010) Expression changes of K+-Cl-cotransporter 2 and Na+-K+-Cl-co-transporter1 in mouse trigeminal subnucleus caudalis following pulpal inflammation. Brain Res Bull 81:561-564.
95. Liaw WJ, Stephens RL Jr, Binns BC, Chu Y, Sepkuty JP, Johns RA, Rothstein JD, and Tao YX (2005) Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 115:60-70.
96. Lin Q, Peng Y, and Willis WD (1994) Glycine and GABAA antagonists reduce the inhibition of primate spinothalamic tract neurons produced by stimulation in periaqueductal gray. Brain Res 654:286-302.
97. Lombardi MS, Kavelaars A, Schedlowski M, Bijlsma JWJ, Okihara KL, Van de Pol M, Ochsmann S, Pawlak C, Schmidt RE, and Heijnen CJ (1999) Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J 13:715-725.
98. Lu Y, Zhu L, and Gao YJ (2011) Pain-related aversion induces astrocytic reaction and proinflammatory cytokine expression in the anterior cingulate cortex in rats. Brain Res Bull 84:178-182.
99. Ludwig J, Binder A, Steinmann J, Wasner G, and Baron R (2008) Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies. J Neurol Neurosurg Psychiatry 79:1268-1273.
100. Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, de Jonckheere C, Minner B, and Raus J (1992) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22:45-53.
101. Maes M, Meltzer HY, Scharpé S, Bosmans E, Suy E, De Meester I, Calabrese J, and Cosyns P (1993) Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res 49:151-165.
102. Maes M, Minner B, and Suy E (1991a) The relationships between the availability of l-tryptophan to the brain, the spontaneous HPA-axis activity, and the HPA-axis responses to dexamethasone in depressed patients. J Amino Acids 1:57-65.
103. Maes M, Schotte C, D'Hondt P, Claes M, Vandewoude M, Scharpe S, and Cosyns P (1991b) Biological heterogeneity of melancholia: results of pattern recognition methods. J Psychiatr Res 25:95-108.
104. Malan T, Mata H, and Porreca F (2002) Spinal GABAA and GABAB receptor pharmacology in a rat model of neuropathic pain. Anesthiol 96:1161-1167.
105. Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, and Farrar JT (2007) Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med 20:434-443.
106. Martuscello RT, Spengler RN, Bonoiu AC, Davidson BA, Helinski J, Ding H, Mahajan S, Kumar R, Bergey EJ, and Knight PR, et al. (2012) Increasing TNF levels solely in the rat hippocampus produces persistent pain-like symptoms. Pain 153:1871-1882.
107. Matrisciano F, Nasca C, Molinaro G, Riozzi B, Scaccianoce S, Raggi MA, Mercolini L, Biagioni F, Mathè AA, and Sanna E, et al. (2010) Enhanced expression of the neuronal K+/Cl-cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats. Brain Res 1325:112-120.
108. Matuzany-Ruban A, Golan M, Miroshnik N, Schreiber G, and Avissar S (2010) Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants. Int J Neuropsychopharmacol 13:83-91.
109. McNally L, Bhagwagar Z, and Hannestad J (2008) Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 13:501-510.
110. Michael-Titus A, Bains S, Jeetle J, and Whelpton R (2000) Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex-a possible mechanism of neuroprotection in major depression. Neurosci 100:681-684.
111. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, and Kreutzer DL (2002) Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 167:753-756.
112. Milligan ED, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O'Connor K, Martin D, Forsayeth JR, Maier SF, and Johnson K, et al. (2005) Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 21:2136-2148.
113. Milligan ED, Sloane EM, Langer SJ, Hughes TS, Jekich BM, Frank MG, Mahoney JH, Levkoff LH, Maier SF, and Cruz PE, et al. (2006) Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126:294-308.
114. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, and Watkins LR (2003) Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23: 1026-1040.
115. Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR Jr, and Kawahara R (2006) Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry 30:1155-1158.
116. Moore P, Landolt HP, Seifritz E, Clark C, Bhatti T, Kelsoe J, Rapaport M, and Gillin JC (2000) Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 23:601-622.
117. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, and Miller AH (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961-966.
118. Navratilova E, Xie JY, King T, and Porreca F (2013) Evaluation of reward from pain relief. Ann N Y Acad Sci 1282:1-11.
119. Newton K and Dixit VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4:1-19.
120. Nie H and Weng HR (2009) Glutamate transporters prevent excessive activation of NMDA receptors and extrasynaptic glutamate spillover in the spinal dorsal horn. J Neurophysiol 101:2041-2051.
121. Niesters M, Martini C, and Dahan A (2013) Ketamine for Chronic Pain: Risks and Benefits. Br J Clin Pharmacol DOI: 10.1111/bcp.12094 [published ahead of print].
122. Norman GJ, Karelina K, Morris JS, Zhang N, Cochran M, and Courtney DeVries A (2010b) Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin. Psychosom Med 72:519-526.
123. Norman GJ, Karelina K, Zhang N, Walton JC, Morris JS, and DeVries AC (2010a) Stress and IL-1b contribute to the development of depressive-like behavior following peripheral nerve injury. Mol Psychiatry 15:404-414.
124. Obreja O, Rathee PK, Lips KS, Distler C, and Kress M (2002) IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1R1, tyrosine kinase, and protein kinase C. FASEB J 16:1497-1503.
125. O'Brien SM, Scott LV, and Dinan TG (2006) Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 188:449-452.
126. O'Brien SM, Scully P, Fitzgerald P, Scott LV, and Dinan TG (2007) Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41:326-331.
127. O'Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, and Dantzer R (2009a) Interferon-g and tumor necrosis factor-a mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29:4200-4209.
128. O'Connor JC, Lawson MA, André C, Briley EM, Szegedi SS, Lestage J, Castanon N, Herkenham M, Dantzer R, and Kelley KW (2009b) Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior. J Immunol 182:3202-3212.
129. O'Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, Kelley KW, and Dantzer R (2009c) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511-522.
130. Oprée A and Kress M (2000) Involvement of the proinflammatory cytokines tumor necrosis factor-a, IL-1 b, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 20:6289-6293.
131. Oraifo S and Omogbai E (2012) Effect of sertraline on the antidepressant-like actions of furosemide and bumetanide in the FST and TST in mice. Int Res J Pharm Pharmacol 2:71-75.
132. Osburg B, Peiser C, Dömling D, Schomburg L, Ko YT, Voigt K, and Bickel U (2002) Effect of endotoxin on expression of TNF receptors and transport of TNF-a at the blood-brain barrier of the rat. Am J Physiol Endocrinol Metab 283:E899-E908.
133. Palin K, Bluthe RM, McCusker RH, Levade T, Moos F, Dantzer R, and Kelley KW (2009) The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNF alpha-induced sickness behavior. Psychopharmacol 201: 549-556.
134. Palin K, McCusker RH, Strle K, Moos F, Dantzer R, and Kelley KW (2008) Tumor necrosis factor-a-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase. Psychopharmacology (Berl) 197:629-635.
135. Parada CA, Yeh JJ, Joseph EK, and Levine JD (2003) Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur J Neurosci 17:1847-1852.
136. Peng YB, Lin Q, and Willis WD (1996) Effects of GABA and glycine receptor antagonists on the activity and PAG-induced inhibition of rat dorsal horn neurons. Brain Res 736:189-201.
137. Piccinini AM and Midwood KS (2010) DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010:1-22.
138. Polazzi E and Contestabile A (2002) Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev Neurosci 13:221-242.
139. Polgár E, Hughes DI, Riddell JS, Maxwell DJ, Puskár Z, and Todd AJ (2003) Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain. Pain 104:229-239.
140. Puskarjov M, Ahmad F, Kaila K, and Blaesse P (2012) Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain. J Neurosci 32:11356-11364.
141. Quan N (2008) Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways? Mol Neurobiol 37:142-152.
142. Quintana J (1992) Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations. J Affect Disord 24:55-62.
143. Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, and Miller AH (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-a: relationship to CNS immune responses and depression. Mol Psychiatry 15:393-403.
144. Raison CL, Woolwine BJ, Demetrashvili MF, Borisov AS, Weinreib R, Staab JP, Zajecka JM, Bruno CJ, Henderson MA, and Reinus JF, et al. (2007) Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther 25:1163-1174.
145. Rakoff-Nahoum S (2006) Why cancer and inflammation? Yale J Biol Med 79:123-130.
146. Rees H, Sluka KA, Westlund KN, and Willis WD (1995) The role of glutamate and GABA receptors in the generation of dorsal root reflexes by acute arthritis in the anaesthetized rat. J Physiol 484:437-445.
147. Reeve AJ, Patel S, Fox A, Walker K, and Urban L (2000) Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 4:247-257.
148. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, and Pollmächer T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445-452.
149. Ren K and Dubner R (2007) Pain facilitation and activity-dependent plasticity in pain modulatory circuitry: role of BDNF-TrkB signaling and NMDA receptors. Mol Neurobiol 35:224-235.
150. Ren K and Dubner R (2010) Interactions between the immune and nervous systems in pain. Nat Med 16:1267-1276.
151. Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, and Quevedo J (2011) Ketamine plus imipramine treatment induces antidepressantlike behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res 221:166-171.
152. Reyes-Gibby CC, Aday LA, Anderson KO, Mendoza TR, and Cleeland CS (2006) Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage 32:118-128.
153. Rivera C, Li H, Thomas-Crusells J, Lahtinen H, Viitanen T, Nanobashvili A, Kokaia Z, Airaksinen MS, Voipio J, and Kaila K, et al. (2002) BDNF-induced TrkB activation down-regulates the K+-Cl-cotransporter KCC2 and impairs neuronal Clextrusion. J Cell Biol 159:747-752.
154. Shoskes DA, Albakri Q, Thomas K, and Cook D (2002) Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol 168:331-335.
155. Sigtermans MJ, van Hilten JJ, Bauer MCR, Arbous MS, Marinus J, Sarton EY, and Dahan A (2009) Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 145:304-311.
156. Sluka KA and Westlund KN (1993) Centrally administered non-NMDA but not NMDA receptor antagonists block peripheral knee joint inflammation. Pain 55:217-225.
157. Sluka KA, Willis WD, and Westlund KN (1993) Joint inflammation and hyperalgesia are reduced by spinal bicuculline. Neuroreport 5:109-112.
158. Strike PC, Wardle J, and Steptoe A (2004) Mild acute inflammatory stimulation induces transient negative mood. J Psychosom Res 57:189-194.
159. Sufka KJ (1994) Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 58:355-366.
160. Sung B, Lim G, and Mao J (2003) Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23:2899-2910.
161. Suzuki T, Kishimoto Y, and Misawa M (1996) Formalin-and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine. Life Sci 59:1667-1674.
162. Tanga FY, Nutile-McMenemy N, and DeLeo JA (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 102:5856-5861.
163. Tornberg J, Voikar V, Savilahti H, Rauvala H, and Airaksinen MS (2005) Behavioural phenotypes of hypomorphic KCC2-deficient mice. Eur J Neurosci 21:1327-1337.
164. Uçeyler N, Valenza R, Stock M, Schedel R, Sprotte G, and Sommer C (2006) Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 54:2656-2664.
165. Van der Does AJ (2001) The effects of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord 64:107-119.
166. Vroon A, Heijnen CJ, and Kavelaars A (2006) GRKs and arrestins: regulators of migration and inflammation. J Leukoc Biol 80:1214-1221.
167. Vroon A, Kavelaars A, Limmroth V, Lombardi MS, Goebel MU, Van Dam AM, Caron MG, Schedlowski M, and Heijnen CJ (2005) G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 174:4400-4406.
168. Walker AK, Budac DP, Bisulco S, Lee AW, Smith RA, Beenders B, Kelley KW, and Dantzer R (2013) NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology 38:1609-1616.
169. Wan W, Janz L, Vriend CY, Sorensen CM, Greenberg AH, and Nance DM (1993) Differential induction of c-Fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin. Brain Res Bull 32:581-587.
170. Wang H, Heijnen CJ, Eijkelkamp N, Garza Carbajal A, Schedlowski M, Kelley KW, Dantzer R, and Kavelaars A (2011) GRK2 in sensory neurons regulates epinephrineinduced signalling and duration of mechanical hyperalgesia. Pain 152:1649-1658.
171. Wang LX and Wang ZJ (2003) Animal and cellular models of chronic pain. Adv Drug Deliv Rev 55:949-965.
172. Watkins LR, Maier SF, and Goehler LE (1995a) Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci 57:1011-1026.
173. Watkins LR, Maier SF, and Goehler LE (1995b) Immune activation: the role of proinflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63:289-302.
174. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, and Maier SF (1994) Characterization of cytokine-induced hyperalgesia. Brain Res 654:15-26.
175. Wei H, Hao B, Huang JL, Ma AN, Li XY, Wang YX, and Pertovaara A (2010) Intrathecal administration of a gap junction decoupler, an inhibitor of Na(+)-K(+)-2Cl (2) cotransporter 1, or a GABA(A) receptor agonist attenuates mechanical pain hypersensitivity induced by REM sleep deprivation in the rat. Pharmacol Biochem Behav 97:377-383.
176. Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, and Maes M (2005) IDO and interferon-a-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 10:538-544.
177. Willemen HL, Eijkelkamp N, Wang H, Dantzer R, Dorn GW 2nd, Kelley KW, Heijnen CJ, and Kavelaars A (2010) Microglial/macrophage GRK2 determines duration of peripheral IL-1b-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling. Pain 150:550-560.
178. Willis WD Jr (1999) Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp Brain Res 124:395-421.
179. Wright CE, Strike PC, Brydon L, and Steptoe A (2005) Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun 19: 345-350.
180. Wu LA, Huang J, Wang W, Wang W, Wang XJ, and Wu SX (2009) Down-regulation of K+-Cl-co-transporter 2 in mouse medullary dorsal horn contributes to the formalin-induced inflammatory orofacial pain. Neurosci Lett 457:36-40.
181. Xie W, Luo S, Xuan H, Chou C, Song G, Lv R, Jin Y, Li W, and Xu J (2006) Betamethasone affects cerebral expressions of NF-kappaB and cytokines that correlate with pain behavior in a rat model of neuropathy. Ann Clin Lab Sci 36: 39-46.
182. Yirmiya R (1996) Endotoxin produces a depressive-like episode in rats. Brain Res 711:163-174.
183. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, and Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864.
184. Zelenka M, Schäfers M, and Sommer C (2005) Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 116:257-263.
185. Zhou S, Bonasera L, and Carlton SM (1996) Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. Neuroreport 7:895-900.